| Net Cash Provided by (Used in) Operating Activities |
$25,966,000 |
USD |
-7426% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$50,610,000 |
USD |
-65% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$27,627,000 |
USD |
84% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
102,572,000 |
shares |
0.02% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,983,000 |
USD |
88% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$510,095,000 |
USD |
355% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$5,228,000 |
USD |
-72% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$71,738,000 |
USD |
-18% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$4,156,000 |
USD |
217% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
$81,907,000 |
USD |
310% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$34,097,000 |
USD |
-12% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
6,800,000 |
shares |
-57% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$15,811,000 |
USD |
265% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$10,777,000 |
USD |
137% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$26,549,000 |
USD |
-109% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
6,800,000 |
shares |
-57% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
$4,004,000 |
USD |
192% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$41,000 |
USD |
-102% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$224,754,000 |
USD |
7.1% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$66,510,000 |
USD |
-3.1% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$19,487,000 |
USD |
531% |
Q3 2025 |
Q3 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$250,000 |
USD |
-149% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$186,751,000 |
USD |
21% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |